Conference call scheduled for Thursday, March 26 at 2:00 p.m. CET / 9:00 a.m. EDT
Mont-Saint-Guibert, Belgium - Cardio3 BioSciences (C3BS) (Euronext Brussels and Paris: CARD), a leader in the discovery and development of specialized cell therapies, today announced that it will report its financial results for the year ended December 31, 2014, on Thursday, March 26, 2015.
A conference call will be held on Thursday, March 26, 2015 at 2:00 p.m. CET / 9:00 a.m. EDT to review the financial results. Christian Homsy, Chief Executive Officer, and Patrick Jeanmart, Chief Financial Officer will deliver a brief presentation, which will be available to download from here 15 minutes before the call commences, followed by a Q&A session. Participants are asked to call the assigned number approximately five minutes before the conference call begins. The call can be accessed by dialing the numbers below and quoting conference ID 10703467.
• Participant International Dial-In + 44 (0)1452 541003
• Belgium 011500193
• France 0170700780
• United States 1-646-741-2120
A recording of the presentation will be available on the Cardio3 Biosciences website following the call.
*** END ***
For more information, please contact:
Cardio3 BioSciences
Christian Homsy, CEO
Julie Grade, Corporate Communications Manager www.c3bs.com
Tel: +32 10 39 41 00
jgrade@c3bs.com
For Europe: Consilium Strategic Communications
Amber Bielecka, Chris Welsh, Laura Thornton Tel : +44 20 3709 5700
cardio3@consilium-comms.com
For France : NewCap
Pierre Laurent, Nicolas Mérigeau Tél. : + 33(0)1 44 71 94 94
cardio3@newcap.fr
For the U.S: The Ruth Group
Lee Roth (Investors), Kirsten Thomas (Media) Tel: +1 646 536 7012 / 7014
lroth@theruthgroup.com kthomas@theruthgroup.com
